A pathways company has followed up its medical and radiation oncology clinical decision tools with a new surgical oncology platform.
Clinical pathways are rapidly being adopted by providers and payers alike, to guide treatment decisions and also manage care costs. Via Oncology, a company that develops these clinical pathways using its in-house expertise of physicians, has announced the launch of a Surgical Oncology Pathways platform, which follows similar platforms for medical and radiation oncology.
In an associated press release the company said that the new platform is initially being rolled out at UPMC and Indiana University Health, for 6 diseases, incorporating key decision points for patient work-up and assessment along with surgical interventions and follow up surveillance plans.
According to Kathy Lokay, CEO and President of Via Oncology, “The Via Pathways program has been central to the quality of care in medical and radiation oncology and we are excited to expand it for use by surgical oncologists as well.”
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More